Our findings provide novel insights into the role of miR-146b in regulating the SMAD4/C-MYC/Cyclin D1 axis in bladder cancer, aligning with previous studies demonstrating miR-146b’s oncogenic potential in various malignancies. Here, CCND1 is linked to urinary bladder carcinoma.